SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Jill S. Manion, John M. Thomason, Vernon C. Langston, Andrew K. Claude, Marjory B. Brooks, Andrew J. Mackin, Kari V. Lunsford, Anticoagulant effects of inhaled unfractionated heparin in the dog as determined by partial thromboplastin time and factor Xa activity, Journal of Veterinary Emergency and Critical Care, 2016, 26, 1
  2. 2
    Alice Morassi, Domenico Bianco, Ed Park, Reid K. Nakamura, George A. White, Evaluation of the safety and tolerability of rivaroxaban in dogs with presumed primary immune-mediated hemolytic anemia, Journal of Veterinary Emergency and Critical Care, 2016, 26, 2
  3. 3
    Selena Lane, Benjamin Brainard, August's Consultations in Feline Internal Medicine, Volume 7, 2016,

    CrossRef

  4. 4
    Cynthia M. Panek, Reid K. Nakamura, Domenico Bianco, Use of enoxaparin in dogs with primary immune-mediated hemolytic anemia: 21 cases, Journal of Veterinary Emergency and Critical Care, 2015, 25, 2
  5. 5
    Amy Dixon-Jimenez, Benjamin M. Brainard, Small Animal Critical Care Medicine, 2015,

    CrossRef

  6. 6
    Dorothy D. Whelchel, Brett S. Tennent-Brown, Steeve Giguère, Kira L. Epstein, Pharmacodynamics of Multi-Dose Low Molecular Weight Heparin in Healthy Horses, Veterinary Surgery, 2013, 42, 4
  7. 7
    Linda Kidd, Nigel Mackman, Prothrombotic mechanisms and anticoagulant therapy in dogs with immune-mediated hemolytic anemia, Journal of Veterinary Emergency and Critical Care, 2013, 23, 1
  8. 8
    Brett S. Tennent-Brown, Kira L. Epstein, Dorothy D. Whelchel, Steeve Giguère, Use of viscoelastic coagulation testing to monitor low molecular weight heparin administration to healthy horses, Journal of Veterinary Emergency and Critical Care, 2013, 23, 3
  9. 9
    Stephanie Ann Smith, Antithrombotic Therapy, Topics in Companion Animal Medicine, 2012, 27, 2, 88

    CrossRef

  10. 10
    Nonya N. Fiakpui, Daniel F. Hogan, Ted Whittem, Henry W. Green III, Eryn A. Shipley, Kimberly A. Sederquist, Dose determination of fondaparinux in healthy cats, American Journal of Veterinary Research, 2012, 73, 4, 556

    CrossRef

  11. 11
    D.M. Babski, B.M. Brainard, A.G. Ralph, J.R. Pittman, A. Koenig, Sonoclot® Evaluation of Single- and Multiple-Dose Subcutaneous Unfractionated Heparin Therapy in Healthy Adult Dogs, Journal of Veterinary Internal Medicine, 2012, 26, 3
  12. 12
    Benjamin M. Brainard, Amie Koenig, Danielle M. Babski, April E. Blong, Jordan R. Scherk, Viscoelastic pharmacodynamics after dalteparin administration to healthy dogs, American Journal of Veterinary Research, 2012, 73, 10, 1577

    CrossRef

  13. 13
    Benjamin M. Brainard, Andrew J. Brown, Defects in Coagulation Encountered in Small Animal Critical Care, Veterinary Clinics of North America: Small Animal Practice, 2011, 41, 4, 783

    CrossRef

  14. 14
    S.E. Helmond, D.J. Polzin, P.J. Armstrong, M. Finke, S.A. Smith, Treatment of Immune-Mediated Hemolytic Anemia with Individually Adjusted Heparin Dosing in Dogs, Journal of Veterinary Internal Medicine, 2010, 24, 3
  15. 15
    Elizabeth L. Breuhl, George Moore, Marjory B. Brooks, J. Catharine Scott-Moncrieff, A Prospective Study of Unfractionated Heparin Therapy in Dogs With Primary Immune-Mediated Hemolytic Anemia, Journal of the American Animal Hospital Association, 2009, 45, 3, 125

    CrossRef

  16. 16
    Amy J. Alwood, Amanda B. Downend, Marjory B. Brooks, Kimberly A. Slensky, Julia A. Fox, Stephen A. Simpson, Lori S. Waddell, James E. Baumgardner, Cynthia M. Otto, Anticoagulant Effects of Low-Molecular-Weight Heparins in Healthy Cats, Journal of Veterinary Internal Medicine, 2007, 21, 3
  17. 17
    Kari V. Lunsford, Andrew J. Mackin, Thromboembolic Therapies in Dogs and Cats: An Evidence-Based Approach, Veterinary Clinics of North America: Small Animal Practice, 2007, 37, 3, 579

    CrossRef